Mark Dewhirst: Clinical Trials

5 trials sponsored by Mark Dewhirst, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 withdrawn, 1 terminated. 2 Early Phase 1, 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 1, Withdrawn 1
Not applicable1Withdrawn 1
Phase 11Completed 1
Phase 21Completed 1
Phase 31Terminated 1

Follow Mark Dewhirst: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Characteristics of a Breast Cancer
EF5, Partial or Total Mastectomy - Breast Cancer
Early Phase 1WithdrawnMark Dewhirst2010-01-012012-12-17
Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca
Hyperthermia - Ovarian Cancer
Not applicableWithdrawnMark Dewhirst2009-04-012014-11-11
Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer
Hyperthermia System, Mitomycin C - Transitional Cell Carcinoma of Bladder, Superficial Bladder Cancer
Early Phase 1CompletedMark Dewhirst152008-04-012015-06-29
Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer
cisplatin, hyperthermia treatment, brachytherapy - Cervical Cancer
Phase 3TerminatedMark Dewhirst1012003-03-012013-09-17
MRI Sarcoma Non Invasive Thermometry
doxorubicin hydrochloride, ifosfamide and mesna, hyperthermia treatment with an MRI Compatible Radiofrequency Extremity Hyperthermia Applicator - Sarcoma
Phase 1 / Phase 2CompletedMark Dewhirst151999-11-012014-09-01

Conditions studied

Breast Carcinoma In Situ (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Carcinoma, Lobular (1)  ·  Non-Muscle Invasive Bladder Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Recurrence (1)  ·  Sarcoma (1)  ·  Uterine Cervical Neoplasms (1)

Interventions

Diathermy (3)  ·  Brachytherapy (1)  ·  Cisplatin (1)  ·  Doxorubicin (1)  ·  Ifosfamide (1)  ·  Mastectomy, Simple (1)  ·  Mesna (1)  ·  Mitomycin (1)  ·  Radiotherapy (1)

Countries

United States (4)

Top investigators

Ellen L. Jones, MD, PhD (2)  ·  Angeles Secord, MD (1)  ·  Brant A Inman, MD, MS (1)  ·  Elizabeth Jewell, MD (1)  ·  Ellen Jones, MD, PhD (1)  ·  Leonard R. Prosnitz, MD (1)  ·  Mark W Dewhirst, DVM, PhD (1)  ·  Zeljko Vujaskovic, MD PhD (1)  ·  Zeljko Vujaskovic, MD, PhD (1)  ·  Zelko Vujaskovic, MD (1)

Results publications

PMID 19994492, PMID 24490762

NIH funding

R01CA040355 (1)